Mineralys Therapeutics Statistics

Total Valuation

MLYS has a market cap or net worth of $3.05 billion. The enterprise value is $2.45 billion.

Market Cap	3.05B
Enterprise Value	2.45B

Important Dates

The last earnings date was Monday, November 10, 2025, after market close.

Earnings Date	Nov 10, 2025
Ex-Dividend Date	n/a

Share Statistics

MLYS has 79.14 million shares outstanding. The number of shares has increased by 29.86% in one year.

Current Share Class	79.14M
Shares Outstanding	79.14M
Shares Change (YoY)	+29.86%
Shares Change (QoQ)	+7.86%
Owned by Insiders (%)	0.94%
Owned by Institutions (%)	78.53%
Float	56.90M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	5.27
P/TBV Ratio	5.29
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 25.50

Current Ratio	25.50
Quick Ratio	25.24
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -42.14% and return on invested capital (ROIC) is -28.29%.

Return on Equity (ROE)	-42.14%
Return on Assets (ROA)	-26.50%
Return on Invested Capital (ROIC)	-28.29%
Return on Capital Employed (ROCE)	-31.94%
Revenue Per Employee	n/a
Profits Per Employee	-$3.36M
Employee Count	51
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +206.77% in the last 52 weeks. The beta is 0.40, so MLYS's price volatility has been lower than the market average.

Beta (5Y)	0.40
52-Week Price Change	+206.77%
50-Day Moving Average	41.17
200-Day Moving Average	22.88
Relative Strength Index (RSI)	41.32
Average Volume (20 Days)	1,896,357

Short Selling Information

The latest short interest is 6.89 million, so 8.71% of the outstanding shares have been sold short.

Short Interest	6.89M
Short Previous Month	6.84M
Short % of Shares Out	8.71%
Short % of Float	12.11%
Short Ratio (days to cover)	4.58

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-184.09M
Pretax Income	-171.36M
Net Income	-171.36M
EBITDA	-184.03M
EBIT	-184.09M
Earnings Per Share (EPS)	-$2.86

Full Income Statement

Balance Sheet

The company has $593.63 million in cash and n/a in debt, giving a net cash position of $593.63 million or $7.50 per share.

Cash & Cash Equivalents	593.63M
Total Debt	n/a
Net Cash	593.63M
Net Cash Per Share	$7.50
Equity (Book Value)	576.43M
Book Value Per Share	7.30
Working Capital	576.28M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-171.37M
Capital Expenditures	n/a
Free Cash Flow	-171.37M
FCF Per Share	-$2.17

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

MLYS does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-29.86%
Shareholder Yield	-29.86%
Earnings Yield	-5.62%
FCF Yield	-5.62%

Analyst Forecast

The average price target for MLYS is $46.40, which is 20.52% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$46.40
Price Target Difference	20.52%
Analyst Consensus	Strong Buy
Analyst Count	6
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1